BackClover Health Investments Overview

Clover Health Investments Cost of Revenue

Cost of Revenue analysis for CLOV.

Quarterly Cost of Revenue

$589.65M
66.83% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$167.26M
76.34% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)